CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 62 enrolled
Drug / intervention
Testosterone 1% gel 1.25 g +7 moredrug
Likely dose
Testosterone 1% gel 1.25 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01327495
NCT01327495Phase 3Completed

Dose Response Effects of Exogenous Testosterone on the Prostate and Comparison With Effects on Body Composition (Short Title: PROS-2)

University of Washington·interventional·Posted Apr 1, 2011·Updated Oct 5, 2017

In Brief

A Phase 3 clinical trial evaluating placebo acyline, placebo gel, and 6 other interventions for Healthy. Completed, enrolled 62 participants across 1 site.

Detailed Summary

The investigators will conduct a three-month, randomized, placebo-controlled trial comparing the effects of increasing doses of androgen supplementation with Testosterone (T) gel on the prostate in healthy men who are treated with acyline to block gonadal androgen production.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 1, 2011
Enrollment StartOct 1, 2011
Primary CompletionJun 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 15.3 years ago

Interventions

placebo acylineother

Placebo acyline subcutaneous injection every 2 weeks

placebo gelother

daily placebo testosterone gel applied transdermally x 12 weeks

Testosterone 1% gel 1.25 gdrug

testosterone 1% gel 1.25 g daily applied transdermally x 12 weeks

Testosterone 1% gel 2.5 gdrug

Testosterone 1% gel 2.5 g daily applied transdermally x 12 weeks

Testosterone 1% gel 5.0 gdrug

Testosterone 1% gel 5.0 g daily applied transdermally x 12 weeks

testosterone 1% gel 10 gdrug

Testosterone 1% gel 10 g daily applied transdermally x 12 weeks

testosterone 1% gel 15 gdrug

Testosterone 1% gel 15 g daily applied transdermally x 12 weeks

Acylinedrug

300 ug/kg subcutaneous injection every 2 weeks